Bank Of New York Mellon Corp Vaccinex, Inc. Transaction History

Bank Of New York Mellon Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	BUY	$2.09 - $5.11 $4,288 - $10,485	2,052 Added 12.9%	17,954 $53,000
Q1 2020 May 06, 2020	SELL	$3.96 - $8.37 $2,558 - $5,407	-646 Reduced 3.9%	15,902 $63,000
Q1 2019 May 14, 2019	SELL	$3.67 - $5.5 $1,835 - $2,750	-500 Reduced 2.93%	16,548 $87,000
Q3 2018 Nov 09, 2018	BUY	$6.95 - $11.64 $118,483 - $198,438	17,048 New	17,048 $0

426K

Ticker VCNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,664,100
Market Cap $240M
Description
Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs. The company offers its products for the treatment of cancer, neurodegenerative diseases, and autoimmune disorders. Its lead product candidate is pepinemab,...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.